EP2714052
SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS TREATED WITH NEUROLEPTIC AGENTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
31.5.2012EP published:
19.9.2018EP application number:
12724631.2
EPO information:
European Patent Register
Max expiry date:
30.5.2032
Title:
SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS TREATED WITH NEUROLEPTIC AGENTS
Timeline
Today
31.5.2012EP application
19.9.2018EP Publication
Owner
Name:
Boehringer Ingelheim International GmbHAddress:
Binger Strasse 173, 55216, Ingelheim am Rhein, DE
Inventor
Name:
WIENRICH, MarionAddress:
Ingelheim Am Rhein, DE
Name:
MAYOUX, EricAddress:
Ingelheim Am Rhein, DE
Priority
Number:
11168641Date:
3.6.2011Country:
EP
Number:
12153052Date:
30.1.2012Country:
EP
Classification
Categories:
A61K 31/7034, A61K 31/551, A61K 31/4515, A61P 3/04, A61P 3/06, A61P 3/08